Loading...
Keywords
Last Name
Institution

Connection

Search Results to Jennifer E. Schuster

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Schuster, Jennifer

Item TypeName
Concept Aerosols
Concept Antibodies, Bacterial
Concept Antibodies, Monoclonal
Concept Antibodies, Viral
Concept Epitopes
Concept Antigens, Viral
Concept Autoantibodies
Concept C-Reactive Protein
Concept DNA, Viral
Concept Drug Combinations
Concept Glucocorticoids
Concept Hypoglycemic Agents
Concept Immunoglobulin G
Concept Influenza Vaccines
Concept Interferon Type I
Concept Membrane Glycoproteins
Concept Organoplatinum Compounds
Concept Oxygen
Concept Phosphoproteins
Concept Receptors, Virus
Concept Replicon
Concept RNA, Messenger
Concept Sodium
Concept Sulfonylurea Compounds
Concept Vaccines
Concept Vaccines, Attenuated
Concept Vaccines, Synthetic
Concept Viral Envelope Proteins
Concept Viral Fusion Proteins
Concept Viral Matrix Proteins
Concept Viral Vaccines
Concept Vaccines, Inactivated
Concept Diphtheria-Tetanus-Pertussis Vaccine
Concept NF-kappa B
Concept Immunoglobulins, Intravenous
Concept Hepatitis B Vaccines
Concept Inflammation Mediators
Concept Cancer Vaccines
Concept Pneumococcal Vaccines
Concept Rotavirus Vaccines
Concept Respiratory Syncytial Virus Vaccines
Concept Yellow Fever Vaccine
Concept Meningococcal Vaccines
Concept RNA, Messenger, Stored
Concept RNA, Small Interfering
Concept Thiazolidinediones
Concept Receptor, Notch1
Concept Sialic Acid Binding Ig-like Lectin 2
Concept NF-kappa B p52 Subunit
Concept Herpes Zoster Vaccine
Concept Interleukin 1 Receptor Antagonist Protein
Concept Papillomavirus Vaccines
Concept Antibodies, Neutralizing
Concept Sorting Nexins
Concept Vaccines, Virus-Like Particle
Concept Programmed Cell Death 1 Receptor
Concept Antibodies, Monoclonal, Humanized
Concept Spike Glycoprotein, Coronavirus
Academic Article Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation.

Search Criteria
  • Pharmaceutical Preparations